Precigen, inc. (XON)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Sep'12Jun'12
Revenues
Revenues

29,838

9,108

23,043

35,986

22,585

33,789

32,448

45,275

39,666

65,267

46,016

54,433

53,747

46,002

48,985

52,501

43,438

41,498

53,367

44,891

33,849

31,092

21,197

11,787

7,854

7,143

6,042

6,690

3,885

2,925

2,726

Operating Expenses
Research and development

-

-

31,480

34,518

-

-

44,885

42,049

37,267

-

36,472

34,011

34,180

28,869

29,035

28,375

25,856

26,197

21,598

20,381

79,307

17,640

14,851

14,434

12,058

12,550

10,672

13,510

11,411

14,364

17,641

Selling, general and administrative

-

-

24,741

21,483

-

-

38,708

34,427

39,737

-

39,277

38,843

35,138

35,362

33,812

30,263

42,881

34,737

23,019

23,673

27,628

19,779

14,853

15,382

13,635

12,297

7,407

7,434

6,480

5,046

6,333

Impairment loss

-

-

626

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

-

-

71,660

73,395

-

-

98,919

95,010

92,317

-

90,763

89,703

85,128

78,592

77,806

75,723

83,971

75,893

61,283

62,321

120,972

50,053

36,244

29,869

25,726

24,869

18,079

20,944

17,891

19,410

23,974

Operating loss

-

-

-48,617

-37,409

-

-

-66,471

-49,735

-52,651

-

-44,747

-35,270

-31,381

-32,590

-28,821

-23,222

-40,533

-34,395

-7,916

-17,430

-87,123

-18,961

-15,047

-18,082

-17,872

-17,726

-12,037

-14,254

-14,006

-16,485

-21,248

Other Expense, Net
Unrealized depreciation in fair value of equity securities and preferred stock, net

-106

5,199

-3,068

5,632

70

-2,635

-7,287

-19,182

-1,096

-6,654

2,175

8,687

-1,622

-13,506

412

-23,469

-22,331

2,484

-30,453

-20,609

115,454

38,475

-37,089

-33,777

21,922

4,739

27,339

7,734

-29,369

-3,940

4,756

Gain on previously held equity investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

7,415

-

-

Interest expense

-

-

4,471

4,358

-

-

3,999

142

99

-

138

181

179

102

227

267

265

232

310

359

343

357

230

40

39

110

6

11

14

17

18

Interest and dividend income

-

-

885

1,031

-

-

6,107

5,746

5,470

-

5,070

4,743

4,624

4,373

4,494

713

610

673

567

344

300

406

202

110

88

108

38

15

5

1

1

Other income, net

-

-

2,772

-2,605

-

-

1,452

-93

-659

-

-1,021

4,879

595

495

-32

676

561

784

589

-326

267

-7

-79

-74

-8

175

-343

3

3

49

26

Total other expense, net

-

-

-3,882

-300

-

-

-3,727

-13,671

3,616

-

6,086

18,128

3,418

-8,740

4,647

-22,347

-21,425

3,709

-29,607

-20,950

115,678

38,517

-37,196

-33,781

21,963

4,924

27,028

7,735

-21,966

-4,005

4,713

Equity in net loss of affiliates

-389

-1,696

-1,647

-1,747

-1,640

-1,728

-2,870

-4,550

-2,460

-3,010

-2,993

-3,333

-4,947

-4,169

-6,255

-5,053

-5,643

-2,379

-2,429

-2,180

-1,956

-1,750

-1,619

-1,355

-536

-216

0

0

-390

-

-

Loss from continuing operations before income taxes

-29,902

-62,172

-54,146

-39,456

-52,913

-237,223

-73,068

-67,956

-51,495

16,672

-41,654

-20,475

-32,910

-45,499

-30,429

-50,622

-67,601

-33,065

-39,952

-40,560

26,599

17,806

-53,862

-53,218

3,555

-13,018

14,991

-6,519

-36,362

-

-

Income tax benefit (expense)

-

-

-512

-525

-

4,110

-14,322

-1,127

-4,086

4,236

-818

-813

-533

-587

-418

-591

-2,281

210

-923

934

795

-126

0

-283

306

0

0

0

0

-

-

Loss from discontinued operations, net of income taxes

-26,056

-

-

-

-9,236

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-55,998

-169,215

-53,634

-38,931

-62,136

-341,722

-58,746

-66,829

-47,409

-33,945

-40,836

-19,662

-32,377

-44,912

-30,011

-50,031

-65,320

-33,275

-39,029

-41,494

25,804

17,932

-53,862

-52,935

3,249

-13,018

14,991

-6,519

-36,362

-20,490

-16,535

Net loss attributable to the noncontrolling interests

0

0

0

-165

-1,427

-1,257

-1,422

-1,447

-1,244

-6,679

-1,147

-998

-978

-775

-1,029

-967

-891

-561

-816

-831

-1,293

-899

-1,137

-892

-866

-814

-507

-556

-51

-

-

Net Income (Loss) Attributable to Parent

-55,998

-169,215

-53,634

-38,766

-60,709

-340,465

-57,324

-65,382

-46,165

-27,266

-39,689

-18,664

-31,399

-44,137

-28,982

-49,064

-64,429

-32,714

-38,213

-40,663

27,097

18,831

-52,725

-52,043

4,115

-12,204

15,498

-5,963

-36,311

-20,490

-16,535

Amounts Attributable to Precigen
Net loss from continuing operations attributable to Precigen

-29,942

-

-

-

-51,473

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss from discontinued operations attributable to Precigen

-26,056

-

-

-

-9,236

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent

-26,056

-

-

-

-9,236

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss) Attributable to Parent

-55,998

-

-

-

-60,709

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Loss per Share
Net loss from continuing operations attributable to Precigen per share, basic and diluted (in dollars per share)

-0.19

-

-

-

-0.34

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss from discontinued operations attributable to Precigen per share, basic and diluted (in dollars per share)

-0.16

-

-

-

-0.06

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of dividends on redeemable convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

4,044

7,942

6,405

5,469

5,362

Undistributed earnings allocated to preferred shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,132

-

-

-

-

Net loss attributable to common shareholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-9,072

8,322

-13,905

-42,716

-25,959

-21,897

Net loss attributable to Precigen per share, basic and diluted (in dollars per share)

-0.35

-1.09

-0.35

-0.25

-0.40

-2.62

-0.44

-0.51

-0.36

-0.23

-0.33

-0.16

-0.26

-0.37

-0.24

-0.42

-0.55

-

-0.34

-0.37

-

-

-0.53

-0.53

-

-

-

-2.45

-

-

-3.99

Weighted average shares outstanding, basic and diluted (in shares)

160,338

155,260

154,596

153,749

152,948

131,575

129,518

129,299

127,693

120,788

120,518

119,731

118,956

118,586

118,346

118,141

116,861

-

112,244

109,318

-

-

99,888

98,892

-

-

-

5,667

-

-

5,484

Net income (loss) attributable to Intrexon per share, basic (in usd per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.26

-

-

-

0.04

-

0.15

-

-7.54

-4.66

-

Net income (loss) attributable to Intrexon per share, diluted (in usd per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.25

-

-

-

0.04

-

0.15

-

-7.54

-4.66

-

Weighted average shares outstanding, basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

106,103

-

-

-

97,325

-

54,305

-

5,661

5,576

-

Weighted average shares outstanding, diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

108,141

-

-

-

99,338

-

56,150

-

5,661

5,576

-

Continuing Operations
Revenues

29,838

-

-

-

22,585

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

18,891

-

-

-

26,938

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Selling, general and administrative

23,018

-

-

-

31,049

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

55,534

-

-

-

72,801

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating loss

-25,696

-

-

-

-50,216

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized and realized appreciation in fair value of equity securities and preferred stock, net

0

-

-

-

449

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

4,592

-

-

-

4,305

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest and dividend income

673

-

-

-

1,361

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income, net

64

-

-

-

546

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other expense, net

-3,855

-

-

-

-1,949

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Equity in net loss of affiliates

-351

-

-

-

-748

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from continuing operations before income taxes

-29,902

-

-

-

-52,913

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax benefit (expense)

40

-

-

-

-13

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from continuing operations

-29,942

-

-

-

-52,900

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration and licensing agreements [Member]
Revenues

10,721

-7,194

6,185

9,097

5,971

17,918

14,324

17,450

19,848

45,240

28,155

28,164

33,065

27,727

30,590

27,481

24,073

21,131

34,726

17,181

14,783

12,955

12,656

11,764

7,837

6,959

6,028

6,674

3,864

2,904

2,705

Products
Revenues

-

-

5,852

7,819

-

-

6,829

9,568

7,152

-

7,670

9,980

8,130

8,259

9,260

10,884

8,555

9,234

9,446

14,266

8,933

7,357

4,115

9

0

-

0

-

-

-

-

Cost of products and services

-

-

8,263

9,176

-

-

8,877

10,639

8,530

-

8,001

8,861

9,006

8,238

9,156

10,753

9,562

9,092

11,215

11,764

8,675

6,725

4,224

53

33

-

0

-

-

-

-

Services
Revenues

-

-

9,924

18,400

-

-

10,414

17,718

12,247

-

9,975

15,884

12,031

9,751

8,706

13,927

10,665

10,766

8,945

13,255

9,957

10,500

4,261

0

0

-

0

-

-

-

-

Cost of products and services

-

-

6,550

8,218

-

-

6,449

7,895

6,783

-

7,013

7,988

6,804

6,123

5,803

6,332

5,672

5,867

5,451

6,503

5,362

5,909

2,316

0

0

-

0

-

-

-

-

Other
Revenues

-

-

1,082

670

-

-

881

539

419

-

216

405

521

265

429

209

145

367

250

189

176

280

165

14

17

20

14

16

21

21

21